Find the Perfect Plan for Your Investment Journey
P
Latest price
52 Week Range
R$4.95 - R$7.86
Next Earnings Date
May 05 2025
Next Earnings Date
May 05 2025
Latest price
Market Cap | R$923.26M |
EV | R$2.22B |
Shares Outstanding | 122.61M |
Beta | 0.82 |
Analyst Rating | NOT_AVAILABLE |
Analyst Target Price | - |
P/E 2025E | - |
P/Revenue 2025E | - |
Revenue | 16.60% |
EPS | 13.60% |
Operating Cash Flow | 66.60% |
Free Cash Flow | 90.30% |
Revenue | - |
EPS | - |
Operating Cash Flow | - |
Free Cash Flow | - |
Gross Margin 2025E | - |
Net Profit Margin 2025E | - |
ROE 2025E | - |
ROCE 2024 | 8.98% |
DPS 2025E | - |
Payout Ratio 2025E | - |
Div. Yield 2025E | - |
DPS Last 3Y CAGR | 28.60% |
Price
%
1M
3M
6M
1Y
3Y
5Y
P
Profarma Distribuidora de Produtos Farmacêuticos S.A.
PFRM3
Sector
Healthcare
Industry
Medical - Distribution
CEO
Birmarcker, Sammy
Employees
7,077
Website
www.profarma.com.brIPO Date
2006-10-26
Headquarters
Avenida José Silva de Azevedo Neto, 155, bloco P, 3º andar, Rio De Janeiro, Rio de Janeiro Brazil
COMPANY
NEWSLETTER
© Copyright 2025, All Rights Reserved